RecruitingPhase 1NCT07297667
Respiratory
Alveolar soft tissue sarcoma
11
studies recruiting now
as of 7 Sept 2026
98
studies registered in total
as of 7 Sept 2026
5
countries with a recruiting site
as of 7 Sept 2026
22 Dec 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT05304585
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
RecruitingPhase 2NCT05333458
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
RecruitingPhase 1NCT04999761
AB122 Platform Study
RecruitingPhase 1NCT06066138
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 11 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Alveolar soft tissue sarcoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Alveolar soft tissue sarcoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (TFE3, ASPSCR1).
Treatments being studied
9 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Catequentinib
Phase 3Dacarbazine (Dacarbazine)
Phase 2Pazopanib (Votrient)
Phase 2Bevacizumab (Abevmy)
Phase 2Cediranib (Recentin)
Phase 2Apl-501
Phase 2Atezolizumab (Atezolizumab component of tecentriq hybreza)
Phase 2Pembrolizumab (Keytruda)
+ 1 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).